BridgeMD
New treatment option for Spinal Metastases
Official title Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
ClinicalTrials.gov ID: NCT07135817
What this study is testing
- What it's testing
- The goal of this interventional clinical trial is to evaluate the efficacy and safety of preoperative hypofractionated Stereotactic Body Radiotherapy (SBRT) in the treatment of patients undergoing surgery for spinal metastases. The main questions this study aims to answer are: Does preoperative SBRT result in local tumor control at the involved spinal segments as assessed by MRI/CT scan at 3 and 6 months postoperatively?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Indication for surgical treatment of a spinal tumor
- Age: older or 18 years
- Estimated survival \> 6 months
- The patient is able to understand the nature, significance and scope of the clinical study in the context of patient information and to base the...
You likely can't join if
- Age: \< 18 years
- Motor deficit or loss of bladder and bowel control that urges an emergency surgical decompression
- Tumor extent does not allow hypofractioned SBRT (1-3 fractions)
The study team makes the final eligibility decision.
Where it's taking place
- Göttingen, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Göttingen, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.